Initial pharmacotherapy in a population of veterans with Parkinson disease

Kari Swarztrauber, Caroline Koudelka, Matthew A. Brodsky

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29% of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20% of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.

Original languageEnglish (US)
Pages (from-to)1425-1426
Number of pages2
Issue number9
StatePublished - May 2006

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Initial pharmacotherapy in a population of veterans with Parkinson disease'. Together they form a unique fingerprint.

Cite this